KLK3 and metastatic prostate carcinoma: He had previously received 3 treatment regimens for metastatic prostate cancer (bicalutamide, leuprolide acetate, and abiraterone acetate), and had a best overall response of SD prior to progression on all 3 regimens with a rapid rise of prostate-specific antigen reported with the bicalutamide regimen.